Keywords: oral, isis, yields, encouraging, ph, data, usa-based

Oral ISIS 301012 yields encouraging Ph I data

Article | 13 February 2006

Print This

USA-based Isis Pharmaceuticals says that a Phase I study of an oral formulation of its anticholesterol drug candidate, ISIS 301012, has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in